Test gene analysis on liquid from a lung biopsy
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This study looks at special lab tests (molecular analysis) done on liquid taken during a bronchoscopy to better understand lung nodules. It may help doctors learn more about what these nodules are, using samples from the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have 1 to 3 lung nodules planned for evaluation, each 20 mm or smaller
- Your medical team plans to do an ultrasound-guided bronchoscopy (called rEBUS)
- Your general health is rated as WHO performance status 0 to 3
- You can sign informed consent (and agree to the procedure and tests)
- You have coverage through a social security or universal health coverage program
- You have not already been diagnosed with lung cancer before the procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks tiny pieces of DNA from a sample taken during a breathing-tube biopsy (EBUS-TBNA) to better identify certain lung cancer changes. It may help doctors learn more about the type of lung cancer and, in some cases, why targeted treatments stop working.
This study collects blood, tissue, and other samples from people with lung nodules, suspected lung cancer, or confirmed lung cancer to find better ways to diagnose and treat the disease. By joining, you help researchers discover new biomarkers that could improve care for future patients.
This study checks whether it’s practical to do gene (DNA) testing on samples taken during EBUS-TBNA, a common breathing-tube biopsy used to stage lung cancer. If it works well, it could make genetic testing faster and easier for people with lung cancer.
This study looks at lung nodules found on CT scans. Researchers will collect data from your breathing tests and CT scans to better understand how these nodules relate to lung cancer.
This study compares two ways to get a larger tissue sample from lymph nodes in the chest after a first small test confirmed cancer. The goal is to see which method provides better material for detailed genetic testing (next generation sequencing) that can guide treatment choices.
This study tests a new microscope that quickly analyzes lung tissue during a bronchoscopy or surgery. It may help doctors make faster, more accurate decisions about your care.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.